Friess Associates’s Medtronic MDT Stock Holding History

Friess Associates’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-42,470	Closed	-$4.82M	–	127
2019 Q4	$4.82M	Buy	42,470 +8,770	+26%	+$962K	0.34%	84
2019 Q3	$3.66M	Buy	+33,700	New	+$3.52M	0.28%	81
2017 Q4	–	Sell	-34,100	Closed	-$2.65M	–	117
2017 Q3	$2.65M	Hold	34,100	–	–	0.23%	78
2017 Q2	$3.03M	Buy	+34,100	New	+$2.88M	0.28%	81
2017 Q1	–	Sell	-1,103	Closed	-$79K	–	143
2016 Q4	$79K	Sell	1,103 -159,397	-99%	-$12.5M	0.01%	134
2016 Q3	$13.9M	Buy	160,500 +158,700	+8,817%	+$13.8M	1.34%	39
2016 Q2	$156K	Hold	1,800	–	–	0.02%	117
2016 Q1	$135K	Hold	1,800	–	–	0.01%	133
2015 Q4	$138K	Buy	+1,800	New	+$135K	0.01%	121
2015 Q1	–	Sell	-137,474	Closed	-$9.93M	–	164
2014 Q4	$9.93M	Sell	137,474 -200,675	-59%	-$13.9M	0.8%	52
2014 Q3	$20.9M	Buy	338,149 +359	+0.1%	+$22.8K	1.79%	22
2014 Q2	$21.5M	Buy	+337,790	New	+$20.5M	1.76%	24

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Friess Associates's MDT Position: Q1 2020 in Review

Friess Associates sold out of Medtronic (MDT) in Q1 2020, closing a stake of 42,470 shares — an estimated $4.82M sold.

Friess Associates first reported a position in MDT in Q2 2014 and held it in 12 quarters. The position peaked at $21.5M in Q2 2014. 1,762 funds tracked by Wall St. Rank hold MDT as of Q1 2020.

Friess Associates reported no remaining Medtronic position as of Q1 2020 after selling out during the quarter.
Friess Associates sold 42,470 Medtronic shares in Q1 2020, an estimated $4.82M.
Friess Associates first reported a position in Medtronic in Q2 2014 and held it in 12 quarters.
Friess Associates's Medtronic position peaked at $21.5M in Q2 2014.
1,762 funds tracked by Wall St. Rank held Medtronic as of Q1 2020.

Based on Friess Associates's 13F filing for Q1 2020, filed 15 May 2020.